Birth Defects Study to Evaluate Pregnancy exposureS (BD-STEPS)
No material or nonsubstantive change to a currently approved collection
No
Regular
Approved without change
04/21/2021
03/24/2021
Previous terms continue: Approved consistent with the understanding that CDC will continue to work with SAMHSA on questions related to illicit drug use. The Agency will include the OMB control number and expiration date (as well as the burden statement) on all questionnaires and forms administered to participants in this collection.
CDC will characterize the limitations given the addition of the COVID-19 vaccination question in all future publications and analyses.
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
02/28/2023
02/28/2023
02/28/2023
8,940
0
8,940
4,433
0
4,433
44,307
0
44,307
The propose Non-substantive Change Request is to to modify questions in the Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS) interview to ask women about receipt of a COVID-19 vaccine in the month before through the end of the pregnancy. The current version of the question asks about COVID-19 vaccine only through the third month of pregnancy.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.